Mutations in BAP1 drive tumour sensitivity to programmed cell death in patient-derived cholangiocarcinoma orgnaoids

Shaojun Shi; Imre F. Schene; Indi P. Joore; Henk P. Roest; Gilles van Tienderen; Ruby Lieshout; Bas Groot Koerkamp; Petra E. de Ruiter; Benedetta Artegiani; Sabine A. Fuchs; Hans Clevers; Luc J. W. van der Laan; Monique M.A. Verstegen

doi:10.1016/s0168-8278(22)01621-x

Related publications

Article2024

Ferroptosis programmed cell death in AD‐derived neurons

Germán Plascencia‐Villa, George Perry

Letter2017

Germline BAP1 mutations also predispose to cutaneous squamous cell carcinoma

Robert V. Rawson, Geoffrey F. Watson, Annabelle M. Maher, Stanley W. McCarthy, John F. Thompson, Richard A Scolyer

Article1996

Mitochondria and programmed cell death: back to the future

Patrice X. Petit, Santos A. Susín, Naoufal Zamzami, Bernard Mignotte, Guido Guido Kroemer

Article2020

Patient-derived pancreatic tumour organoids identify therapeutic responses to oncolytic adenoviruses

Giulia Raimondi, Ana Mato Berciano, Silvia Pascual-Sabater, Maria Rovira-Rigau, Míriam Cuatrecasas, Constantino Fondevila, Santiago Sánchez‐Cabús, Harry Begthel, Sylvia F. Boj, Hans Clevers, Cristina Fillat, Giulia Raimondi, Ana Mato Berciano, Silvia Pascual-Sabater, Maria Rovira-Rigau, Míriam Cuatrecasas, Constantino Fondevila, Santiago Sánchez‐Cabús, Harry Begthel, Sylvia F. Boj, Hans Clevers, Cristina Fillat

Article2014

17. Peritoneal epithelioid mesothelioma in a patient with metastatic melanoma - an association seen in BAP1 mutations

Annalisa Gatt, Oana Crainic, John F. Thompson, Richard A Scolyer, S. McCarthy, Ruta Gupta